MedTrace Logo

Evaluation of Gastrointestinal pH and Motility After the Consumption of Milk

NCT05471206 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2024-03-22

No results posted yet for this study

Summary

This pilot study is designed as a monocentric, open label, interventional, parallel arms, controlled clinical trial. The aim of the study is to assess the gastrointestinal pH and motility after the consumption of milk.

The clinical study is categorized as an interventional research involving the human person with low risks and constraints (RIPH 2) and which does not assess a health product.

The milk and medical device used in this clinical study are both authorized and already commercialized in France.

Conditions

  • Healthy

Interventions

OTHER

Milk and SmartPill intakes

During visit V2, the subject will ingest the SmartPill capsule. Then, subjects will drink milk.

Sponsors & Collaborators

  • BioFortis

    collaborator OTHER

  • Lactalis

    lead INDUSTRY

Principal Investigators

  • Mathilde Guerville · Lactalis

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-24
Primary Completion
2024-02-15
Completion
2024-02-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05471206 on ClinicalTrials.gov